EDTUTC-4 New YorkLog in Sign up

ORIC
Oric Pharmaceuticals, Inc. Common Stock
stockNASDAQ

At CloseOct 5, 2026 3:59:59 PM EDT

12.47USD+2.171%(+0.27)1,393,916

10.75Bid12.49Ask1.74Spread

Pre-marketOct 5, 2026 9:29:59 AM EDT

12.60USD+3.195%(+0.39)

After-hoursOct 5, 2026 4:59:30 PM EDT

12.69USD+1.764%(+0.22)

ORIC News

Day breaks

04:20 PM EDTORIC partners with Cancer Research UK on cancer drug development ·

Investing.com

04:01 PM EDTORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development ·

GlobeNewswire Inc.

04:30 PM EDTORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) ·

GlobeNewswire Inc.

08:15 PM EDTOric Pharmaceuticals CFO Dominic Piscitelli sells $8,102 in shares ·

Investing.com

06:54 AM EDTBTIG initiates ORIC Pharmaceuticals stock coverage with buy rating ·

Investing.com

06:31 AM EDTORIC Pharmaceuticals, Inc. (ORIC) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript ·

Seeking Alpha

10:54 AM EDTORIC at Morgan Stanley conference: cash-rich push into late-stage cancer ·

Investing.com

05:46 AM EDTORIC (ORIC) Doubles Down On Prostate Cancer With Phase 3 Launch ·

Insider Monkey

04:30 PM EDTORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) ·

GlobeNewswire Inc.